10.06.2015 • News

Chemours Spin-off from DuPont Finalized for July 1

DuPont’s board of directors has given final approval for the spin-off of the US group’s performance chemical business into a new standalone company known as The Chemours Company with effect from July 1, 2015.
In the spin-off, DuPont’s shareholders will receive one share of Chemours common stock for every five shares they hold in DuPont.
Trading of the shares is expected to begin on or about June 19 under the symbol “CC WI” on the New York Stock Exchange and continue through June 30.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read